We use cookies to analyze site traffic and improve your experience.
By accepting, you consent to the use of analytics cookies.

2882:TWSECathay Financial Holdings Co., Ltd. Analysis

Data as of 2026-06-18 - not real-time

NT$115.50

Latest Price

5/10Risk

Risk Level: Medium

Executive Summary

Cathay Financial Holding is trading at TWD115.5, well above its 20‑day (≈95.3) and 50‑day (≈83.8) SMAs, indicating strong upward momentum. The 200‑day SMA (≈73.2) also lies far below the current price, confirming a long‑term bullish trend. Technicals show a bullish MACD crossover with the line (≈8.28) above the signal (≈6.49) and a positive histogram. However, the 14‑day RSI is at an elevated 81, suggesting the stock may be overbought in the near term. Volume trend is decreasing, which could limit short‑term upside. Valuation‑wise, the trailing P/E of 16.36 is slightly below the industry average of 16.92, implying the stock is at least fairly valued.
The dividend yield of 3.2% and a payout ratio under 50% provide attractive income. The company reported robust Q1 2026 earnings with adjusted net income of TWD48.6 bn and an adjusted EPS of TWD3.31, driving an ROE of 16.9% on a consolidated basis. Despite a negative operating cash flow, the balance sheet holds over TWD1.55 tn in cash, offsetting the debt load. Beta of 0.43 indicates low market sensitivity, while 30‑day volatility of ~44% reflects price swings. The Fear & Greed Index at “Extreme Greed” underscores strong market optimism. Given these dynamics, the stock appears positioned for continued upside but may face short‑term consolidation near the resistance of TWD117.5.

Market Outlook

Short Term

< 1 year
Neutral
Model confidence: 6/10

Key Factors

  • Bullish MACD but overbought RSI
  • Decreasing volume trend
  • Proximity to technical resistance at TWD117.5

Medium Term

1–3 years
Positive
Model confidence: 8/10

Key Factors

  • Strong Q1 earnings and rising ROE
  • Fair valuation relative to industry
  • Attractive dividend yield with sustainable payout

Long Term

> 3 years
Positive
Model confidence: 9/10

Key Factors

  • Robust cash reserves offsetting debt
  • Low beta indicating defensive profile
  • Consistent dividend and earnings growth trajectory

Key Metrics & Analysis

Financial Health

Revenue Growth94.20%
Profit Margin7.72%
P/E Ratio16.4
Debt/Equity108.98
P/B Ratio2.1
Op. Cash FlowNT$-37978628096
Industry P/E16.9

Technical Analysis

TrendBullish
RSI81.2
SupportNT$78.20
ResistanceNT$117.50
MA 20NT$95.31
MA 50NT$83.78
MA 200NT$73.21
MACDBullish
VolumeDecreasing
Fear & Greed Index91.52

Valuation

Target PriceNT$93.46
Upside/Downside-19.09%
GradeFair
TypeBlend
Dividend Yield3.20%

Risk Assessment

Beta0.43
Volatility44.76%
Sector RiskLow
Reg. RiskMedium
Geo RiskLow
Currency RiskLow
Liquidity RiskLow

This analysis may contain inaccuracies and is provided for informational and research purposes only. It is not personal investment advice, a recommendation, or an instruction to buy, sell, or hold any asset.